CORRECTED-Valeant Pharma says may buy back securities worth up to $1.5 bln

Wed Jan 22, 2014 9:12am EST

(Corrects headline and paragraph 1 to say the company may, not would, buy back up to $1.5 bln in securities)

Jan 22 (Reuters) - Valeant Pharmaceuticals International Inc , Canada's biggest publicly traded drugmaker, said it may buy back securities worth up to $1.5 billion.

The company said the buyback program, which commenced on Nov. 22, would include repurchase of convertible notes, senior notes and common shares.

The program replaces the company's previous buyback program which expired on Nov. 14, the company said in a statement. (Reporting By Anannya Pramanick in Bangalore; Editing by Don Sebastian)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

California state worker Albert Jagow (L) goes over his retirement options with Calpers Retirement Program Specialist JeanAnn Kirkpatrick at the Calpers regional office in Sacramento, California October 21, 2009. Calpers, the largest U.S. public pension fund, manages retirement benefits for more than 1.6 million people, with assets comparable in value to the entire GDP of Israel. The Calpers investment portfolio had a historic drop in value, going from a peak of $250 billion in the fall of 2007 to $167 billion in March 2009, a loss of about a third during that period. It is now around $200 billion. REUTERS/Max Whittaker   (UNITED STATES) - RTXPWOZ

How to get out of debt

Financial adviser Eric Brotman offers strategies for cutting debt from student loans and elder care -- and how to avoid money woes in the first place.  Video